The European regulatory framework for medicinal products covers authorised cannabis-containing pharmaceutical products. The latter are subject to the general requirements applicable to medicinal products, meaning that the European Union does not have a specific framework for cannabis-derived medicinal products
This report seeks to outline the labelling and packaging requirements that cannabis-containing medicinal products need to comply with when their placing on the European market is authorised.
Sergi holds a Master’s degree in European Union Law from the University of Amsterdam, where he also participated in the Fair Work and Equality Law Clinic. He graduated in Law from the University of Barcelona in 2019. He worked as a legal research intern at Global Human Rights Defence, an NGO that monitors human rights violations worldwide. He also engaged in a traineeship program in an Egyptian law firm in 2019, arranged by AIESEC.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
LATEST ALERTS
